Aged dystrophin-null canines are excellent models for studying experimental therapies for Duchenne muscular dystrophy, a lethal muscle disease caused by dystrophin deficiency. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.